Drawing for CAPCELL

USPTO serial 78586410

CAPCELL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
CORWIN, KEVIN SCOTT
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CAPCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

HERBERT DUBNO

HERBERT DUBNO KARL F ROSS PC5676 RIVERDALE AVE STE 310BRONX (RIVERDALE), NY 10471-0900UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001BIOLOGICAL MATERIAL, NAMELY, PROKARYOTIC AND EUKARYOTIC CELLS, NAMELY, VIRUS PRODUCING CELLS, ANTIBODY PRODUCING CELLS, CYTOCHROME P450 PRODUCING CELLS AND CYTOKINE PRODUCING CELLS, ALL SOLD IN CAPSULES FOR USE IN AGRICULTURAL, INDUSTRIAL AND CHEMICAL PROCESSES AND FOR USE IN DIAGNOSTIC APPLICATIONS FOR SCIENTIFIC AND RESEARCH USEACTIVE
005UNIT DOSE CAPSULES SOLD FILLED AND CONTAINING BIOLOGICALLY ACTIVE MATERIAL FOR PHARMACEUTICAL, AND MEDICAL DIAGNOSTIC APPLICATIONS, NAMELY FOR THE TREATMENT AND PREVENTION OF CANCER, DIABETES, CARDIOVASCULAR DISORDERS, METABOLIC DISORDERS, INFLAMMATORY DISEASES, NEUROLOGICAL DISORDERS, ADIPOSITY, RHEUMATIC DISORDERS, AUTOIMMUNE DISEASES OR HEREDITARY DISEASESACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 8, 2008MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 8, 2008ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 11, 2008CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 8, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2008DOCKASSIGNED TO EXAMINER
Nov 28, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 27, 2007ACECAMENDMENT FROM APPLICANT ENTERED
Nov 27, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 27, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2007MAILPAPER RECEIVED
Nov 16, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2007D1BRTEAS DELETE 1(B) BASIS RECEIVED
May 24, 2007CNSLLETTER OF SUSPENSION MAILED
May 23, 2007CNSLSUSPENSION LETTER WRITTEN
Apr 26, 2007ACECAMENDMENT FROM APPLICANT ENTERED
Apr 26, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2007ALIEASSIGNED TO LIE
Mar 26, 2007MAILPAPER RECEIVED
Oct 2, 2006CNSLLETTER OF SUSPENSION MAILED
Sep 30, 2006CNSLSUSPENSION LETTER WRITTEN
Aug 24, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Aug 4, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2006MAILPAPER RECEIVED
Feb 22, 2006CNSLLETTER OF SUSPENSION MAILED
Feb 22, 2006CNSLSUSPENSION LETTER WRITTEN
Jan 19, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Dec 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2005MAILPAPER RECEIVED
Oct 17, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2005DOCKASSIGNED TO EXAMINER
Mar 18, 2005NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance